CONMED Corporation Announces Second Quarter 2015 Financial Results

Go back to CONMED Corporation Announces Second Quarter 2015 Financial Results

Northland Capital Markets Downgrades CONMED (CNMD) to Market Perform

July 22, 2015 7:19 AM EDT

Northland Capital Markets downgraded CONMED (NASDAQ: CNMD) from Outperform to Market Perform with a price target of $58.00 (from $65.00), saying 2nd-half guidance may be too optimistic.

Analyst Mark Landy commented, "CNMD reported in line 2Q revenues of $181M but missed our and the... More

Needham & Company Raises Price Target to $60 Following Conmed's (CNMD) 2Q Miss

July 22, 2015 6:58 AM EDT

Needham & Company reiterated a Buy rating on CONMED (NASDAQ: CNMD), and raised the price target to $60.00 (from $56.00), following 2Q15. CNMD's reported revenue was $181.0M vs. consensus of $182.3M. EPS was $0.36 vs. consensus of $0.44. Analyst Mike Matson said that investors may give management the benefit of... More

Conmed (CNMD) Misses Q2 EPS by 8c, Maintains FY15 Guidance

July 21, 2015 4:04 PM EDT

Conmed (NASDAQ: CNMD) reported Q2 EPS of $0.36, $0.08 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $181 million versus the consensus estimate of $182.6 million.

2015 Outlook

The Company reiterated its previously disclosed constant currency sales guidance, which calls... More